Showing 1 - 20 results of 72 for search 'M. Juliana McElrath', query time: 0.05s Refine Results
  1. 1
    Dynamics of viral evolution and CTL responses in HIV-1 infection.

    Dynamics of viral evolution and CTL responses in HIV-1 infection. by Yi Liu, John P McNevin, Sarah Holte, M Juliana McElrath, James I Mullins

    Published 2011-01-01
    Get full text
    Article
  2. 2
    Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release

    Machine learning identifies molecular regulators and therapeutics for targeting SARS‐CoV2‐induced cytokine release by Marina Chan, Siddharth Vijay, John McNevin, M Juliana McElrath, Eric C Holland, Taranjit S Gujral

    Published 2021-09-01
    Get full text
    Article
  3. 3
    Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies.

    Profiles of human serum antibody responses elicited by three leading HIV vaccines focusing on the induction of Env-specific antibodies. by Michael Vaine, Shixia Wang, Qin Liu, James Arthos, David Montefiori, Paul Goepfert, M Juliana McElrath, Shan Lu

    Published 2010-11-01
    Get full text
    Article
  4. 4
    Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans.

    Pre-existing adenovirus immunity modifies a complex mixed Th1 and Th2 cytokine response to an Ad5/HIV-1 vaccine candidate in humans. by Samuel O Pine, James G Kublin, Scott M Hammer, Joleen Borgerding, Yunda Huang, Danilo R Casimiro, M Juliana McElrath

    Published 2011-04-01
    Get full text
    Article
  5. 5
    Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based modeling study.

    Immune-correlates analysis of an HIV-1 vaccine efficacy trial reveals an association of nonspecific interferon-γ secretion with increased HIV-1 infection risk: a cohort-based model... by Yunda Huang, Ann Duerr, Nicole Frahm, Lily Zhang, Zoe Moodie, Steve De Rosa, M Juliana McElrath, Peter B Gilbert

    Published 2014-01-01
    Get full text
    Article
  6. 6
    In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells--A Tool to Interrogate a Functional Immune Response Ex Vivo.

    In Situ Staining and Laser Capture Microdissection of Lymph Node Residing SIV Gag-Specific CD8+ T cells--A Tool to Interrogate a Functional Immune Response Ex Vivo. by Annelie Tjernlund, Adam Burgener, Jessica M Lindvall, Tao Peng, Jia Zhu, Lars Öhrmalm, Louis J Picker, Kristina Broliden, M Juliana McElrath, Lawrence Corey

    Published 2016-01-01
    Get full text
    Article
  7. 7
    Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054).

    Safety and immunogenicity of a replication-defective adenovirus type 5 HIV vaccine in Ad5-seronegative persons: a randomized clinical trial (HVTN 054). by Laurence Peiperl, Cecilia Morgan, Zoe Moodie, Hongli Li, Nina Russell, Barney S Graham, Georgia D Tomaras, Stephen C De Rosa, M Juliana McElrath, NIAID HIV Vaccine Trials Network

    Published 2010-10-01
    Get full text
    Article
  8. 8
    Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.

    Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study. by Fusheng Li, Adam C Finnefrock, Sheri A Dubey, Bette T M Korber, James Szinger, Suzanne Cole, M Juliana McElrath, John W Shiver, Danilo R Casimiro, Lawrence Corey, Steven G Self

    Published 2011-01-01
    Get full text
    Article
  9. 9
    Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles.

    Trivalent adenovirus type 5 HIV recombinant vaccine primes for modest cytotoxic capacity that is greatest in humans with protective HLA class I alleles. by Stephen A Migueles, Julia E Rood, Amy M Berkley, Tiffany Guo, Daniel Mendoza, Andy Patamawenu, Claire W Hallahan, Nancy A Cogliano, Nicole Frahm, Ann Duerr, M Juliana McElrath, Mark Connors

    Published 2011-02-01
    Get full text
    Article
  10. 10
    Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination.

    Decreased pre-existing Ad5 capsid and Ad35 neutralizing antibodies increase HIV-1 infection risk in the Step trial independent of vaccination. by Cheng Cheng, Lingshu Wang, Jason G D Gall, Martha Nason, Richard M Schwartz, M Juliana McElrath, Steven C DeRosa, John Hural, Lawrence Corey, Susan P Buchbinder, Gary J Nabel

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine Efficacy Trials.

    Pooled-Peptide Epitope Mapping Strategies Are Efficient and Highly Sensitive: An Evaluation of Methods for Identifying Human T Cell Epitope Specificities in Large-Scale HIV Vaccine... by Andrew Fiore-Gartland, Bryce A Manso, David P Friedrich, Erin E Gabriel, Greg Finak, Zoe Moodie, Tomer Hertz, Stephen C De Rosa, Nicole Frahm, Peter B Gilbert, M Juliana McElrath

    Published 2016-01-01
    Get full text
    Article
  12. 12
    Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report

    Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report by Milton Maciel, Rama R. Amara, Katharine J. Bar, Shane Crotty, Steven G. Deeks, Christopher Duplessis, Gaurav Gaiha, M. Juliana McElrath, Andrew McMichael, Amy Palin, Rachel Rutishauser, Stuart Shapiro, Stephen T. Smiley, M. Patricia D’Souza

    Published 2024-02-01
    Get full text
    Article
  13. 13
    Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report

    Author Correction: Exploring synergies between B- and T-cell vaccine approaches to optimize immune responses against HIV—workshop report by Milton Maciel, Rama R. Amara, Katharine J. Bar, Shane Crotty, Steven G. Deeks, Christopher Duplessis, Gaurav Gaiha, M. Juliana McElrath, Andrew McMichael, Amy Palin, Rachel Rutishauser, Stuart Shapiro, Stephen T. Smiley, M. Patricia D’Souza

    Published 2024-03-01
    Get full text
    Article
  14. 14
    A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity.

    A novel HIV vaccine adjuvanted by IC31 induces robust and persistent humoral and cellular immunity. by Laura Pattacini, Gregory J Mize, Jessica B Graham, Tayler R Fluharty, Tisha M Graham, Karen Lingnau, Benjamin Wizel, Beatriz Perdiguero, Mariano Esteban, Giuseppe Pantaleo, Mingchao Shen, Gregory A Spies, M Juliana McElrath, Jennifer M Lund

    Published 2012-01-01
    Get full text
    Article
  15. 15
    Leveraging lessons learned from the COVID-19 pandemic for HIV

    Leveraging lessons learned from the COVID-19 pandemic for HIV by Thomas Calder, Tina Tong, Dale J. Hu, Jerome H. Kim, Karen L. Kotloff, Richard A. Koup, Mary A. Marovich, M. Juliana McElrath, Sarah W. Read, Merlin L. Robb, Philip O. Renzullo, M. Patricia D’Souza

    Published 2022-08-01
    Get full text
    Article
  16. 16
    Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection

    Longitudinal immune profiling after radiation-attenuated sporozoite vaccination reveals coordinated immune processes correlated with malaria protection by Fergal J. Duffy, Nina Hertoghs, Ying Du, Maxwell L. Neal, Damian Oyong, Suzanne McDermott, Nana Minkah, Jason Carnes, Katharine V. Schwedhelm, M. Juliana McElrath, Stephen C. De Rosa, Evan Newell, John D. Aitchison, Ken Stuart

    Published 2022-12-01
    Get full text
    Article
  17. 17
    Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant protein vaccine candidate

    Whole‐blood cytokine secretion assay as a high‐throughput alternative for assessing the cell‐mediated immunity profile after two doses of an adjuvanted SARS‐CoV‐2 recombinant prote... by Stephen C De Rosa, Kristen W Cohen, Matthew Bonaparte, Bo Fu, Sanjay Garg, Catherine Gerard, Paul A Goepfert, Ying Huang, Daniel Larocque, M. Juliana McElrath, Daryl Morris, Robbert Van der Most, Guy deBruyn, Anke Pagnon

    Published 2022-01-01
    Get full text
    Article
  18. 18
    Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response.

    Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response. by Ryan M Troyer, John McNevin, Yi Liu, Shao Chong Zhang, Randall W Krizan, Awet Abraha, Denis M Tebit, Hong Zhao, Santiago Avila, Michael A Lobritz, M Juliana McElrath, Sylvie Le Gall, James I Mullins, Eric J Arts

    Published 2009-04-01
    Get full text
    Article
  19. 19
    Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection.

    Transient Peripheral Immune Activation follows Elective Sigmoidoscopy or Circumcision in a Cohort Study of MSM at Risk of HIV Infection. by Javier R Lama, Shelly T Karuna, Shannon P Grant, Edith M Swann, Carmela Ganoza, Patricia Segura, Silvia M Montano, Martin Lacherre, Stephen C De Rosa, Susan Buchbinder, Jorge Sanchez, M Juliana McElrath, Maria P Lemos, HVTN 914 Study Team

    Published 2016-01-01
    Get full text
    Article
  20. 20
    Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection

    Upregulation of IFN-stimulated genes persists beyond the transitory broad immunologic changes of acute HIV-1 infection by Romel D. Mackelprang, Abdelali Filali-Mouhim, Brian Richardson, Francois Lefebvre, Elly Katabira, Allan Ronald, Glenda Gray, Kristen W. Cohen, Nichole R. Klatt, Tiffany Pecor, Connie Celum, M. Juliana McElrath, Sean M. Hughes, Florian Hladik, Mark J. Cameron, Jairam R. Lingappa

    Published 2023-04-01
    Get full text
    Article

Search Tools: